Vietnam Tightens Herbal Extract Import GMP Rules

On July 9, 2026, Vietnam’s Ministry of Health and the Drug Administration of Vietnam (DAV) put into effect Circular No. 38/2026, revising import documentation requirements for Herbal Extract. The change matters most to Chinese exporters, Vietnam importers, regulatory affairs teams, and supply chain operators because it shifts GMP certificate acceptance toward province-level issuance in China and sets a near-term transition to CA-authenticated electronic signatures only, making document readiness a practical trade issue rather than a routine compliance detail.

What the new filing requirement now says

According to the information provided, all imported Herbal Extract must be accompanied by a GMP certificate issued by a provincial drug regulatory authority in China. The circular took effect on July 9, 2026.

The same notice also states that, starting from September 1, 2026, Vietnam will accept only electronic versions carrying a CA-authenticated electronic signature linked to China’s national drug regulatory system. Paper certificates will no longer be accepted.

For Chinese exporting companies, the update also means they must complete digital signature filing with the relevant provincial drug regulatory authority.

Where the immediate pressure is likely to appear

Export documentation teams face a narrower acceptance standard

From an industry perspective, Chinese companies shipping Herbal Extract to Vietnam may be affected first at the document preparation stage. The key issue is not only whether a GMP certificate exists, but whether the issuing authority and signature format match the revised Vietnamese requirement. What deserves closer attention is the risk of shipment disruption if existing paper-based or differently issued certificates are still being used in active export workflows.

Vietnam importers and buyers may need tighter pre-shipment checks

Vietnam-side importers, procurement teams, and buyers may be affected in supplier qualification and customs-facing document review. Analysis shows that the rule change can shift more responsibility upstream, requiring buyers to verify certificate origin, electronic signature status, and filing readiness before cargo moves. In practice, this can affect supplier confirmation timing and acceptance of shipping documents.

Supply chain service providers may see more compliance coordination work

Customs brokers, trade service providers, and cross-border documentation teams may be affected because the change combines regulatory qualification with digital document format requirements. Observably, the operational burden may concentrate in pre-clearance review, document validation, and communication among exporter, importer, and service provider when a certificate format does not align with the new standard.

Manufacturing and sourcing functions may need to revisit supplier readiness

For companies that source Herbal Extract for downstream processing or product use, the impact may appear in supplier management rather than production itself. Analysis shows that procurement and quality teams may need to confirm whether current Chinese suppliers can obtain the required province-level GMP certificate and complete digital signature filing in time for orders tied to the September 1 transition.

What companies should be checking now

Confirm who issued the GMP certificate

The first practical checkpoint is whether the GMP certificate used for Vietnam-bound Herbal Extract is issued by the appropriate provincial drug regulatory authority in China. This is a document-origin issue, not only a certificate-presence issue.

Separate the current rule from the September digital cutoff

Companies should distinguish between the rule already in force on July 9, 2026 and the stricter document-format requirement taking effect on September 1, 2026. That distinction matters for shipment planning, internal review timing, and customer communication, especially where paper documentation may still be circulating.

Check digital signature filing status early

Because the information provided states that Chinese exporters must complete provincial digital signature filing, exporters should pay attention to whether this filing has been completed before the electronic-only acceptance date arrives. For active Vietnam business, this is likely to become a scheduling and execution issue rather than a purely legal reading issue.

Review contract and delivery communication with counterparties

Importers, exporters, and service partners should closely review which party is responsible for document validation and at what stage that validation occurs. Observably, the move away from paper certificates could make pre-shipment coordination more important, particularly for orders scheduled around the September 1 deadline.

Why this looks larger than a routine paperwork revision

Analysis shows that this update should not be read only as a formal change in filing format. It also signals that Vietnam is drawing a clearer line around document provenance and digital verifiability for imported Herbal Extract. At the same time, it is more appropriate to understand this as an implementation-sensitive regulatory development rather than a fully settled market outcome, because the business effect will depend on how quickly exporters and importers align their documentation processes.

Observably, the most relevant point for the industry is the combination of two thresholds: authority-level recognition and electronic signature recognition. That combination can matter more than a normal certificate renewal cycle because it affects whether documents are admissible at all.

How the market should interpret the change for now

At this stage, the update is best understood as a concrete near-term compliance change with possible longer-term signaling value. The confirmed fact is that Vietnam has revised the GMP certificate requirements for imported Herbal Extract and set a deadline after which paper certificates will no longer be accepted. The broader industry meaning still requires continued observation, particularly around execution, document review practice, and how consistently counterparties adapt before the electronic-only date.

Basis of this article and what still needs verification

This article is based on the user-provided news title, event date, and event summary regarding Vietnam’s revised import rules for Herbal Extract. Information of this kind is commonly cross-checked against official notices, regulator announcements, company compliance disclosures, industry association updates, authoritative media coverage, and standard-related documents.

No specific official source link was provided in the input, so the exact source document link remains to be verified on an ongoing basis. What deserves continued attention is whether any follow-up clarification, implementation guidance, or procedural interpretation is issued regarding certificate format, digital signature validation, or practical filing steps.